新型化合物作为治疗精神疾病或中枢神经系统疾病的5‐HT2A激动剂
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
为治疗精神疾病和中枢神经系统疾病,提出了作为血清素5-HT2A激动剂的新化合物. 这些5-HT2A激动剂为神经和精神疾病提供了新的治疗潜力.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 摘要介绍了新的化学实体,它们被设计为色胺5-HT2A受体的激动剂.
- 这些化合物用于制药应用,特别针对中枢神经系统 (CNS) 疾病和精神疾病.
更多相关视频
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
CNS Stimulants: Psychedelic Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antipsychotic Drugs: Typical and Atypical Agents
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
